Lombard Odier Asset Management (USA) Corp

Holdings History for Silence Therapeutics plc - Ordinary Shares, par value GBP 0.05 per share (the "Shares")

Investment type: Equity / Ordinary Shares, par value GBP 0.05 per share (the "Shares")
Latest Disclosed Shares Owned: 5,935,955 shares
Security Ownership %: 4.2%

Lombard Odier Asset Management (USA) Corp ownership in Silence Therapeutics plc Ordinary Shares, par value GBP 0.05 per share (the "Shares")

09 Feb 2026 - Lombard Odier Asset Management (USA) Corp has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,935,955 shares of Silence Therapeutics plc Ordinary Shares, par value GBP 0.05 per share (the "Shares"). This represents 4.2% ownership of the company. In their previous filing dated 11 Feb 2025, Lombard Odier Asset Management (USA) Corp had reported owning 10,713,627 shares, indicating a decrease of +45%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Lombard Odier Asset Management (USA) Corp	4.2%	-42%		5,935,955	-4,777,672	-45%		13G/A	31 Dec 2025	09 Feb 2026, 13:16
Lombard Odier Asset Management (USA) Corp	7.6%			10,713,627				13G/A	31 Dec 2024	11 Feb 2025, 18:41